Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (631-640 of 1,253) with videos related to

Pageof 126
Sort By:
The American Journal of Cardiology|January 28, 2010
Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI)John K French, Anne S Hellkamp, Paul W Armstrong, et al.
American Heart Journal|November 19, 2011
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programCono A Ariti, John G F Cleland, Stuart J Pocock, et al.
European Heart Journal|September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndromePh Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.
The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.
Journal of Electrocardiology|January 1, 1994
From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoringM W Krucoff, C L Green, F E Harrell, et al.
Stroke|November 2, 2017
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or WarfarinDragos Vinereanu, Renato D Lopes, Hillary Mulder, et al.
American Heart Journal|March 5, 2019
Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM TrialAbhinav Sharma, Robert J Mentz, Bradi B Granger, et al.
Archives of Internal Medicine|February 25, 2009
Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsPeter R Sinnaeve, P Gabriel Steg, Keith A A Fox, et al.
American Heart Journal|March 12, 2011
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaborationSanneke P M de Boer, Elizabeth H Barnes, Cynthia M Westerhout, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
Pageof 126

Showing results (631-640 of 1,253) with videos related to

Sort By:
Pageof 126
The American Journal of Cardiology|January 28, 2010
Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI)John K French, Anne S Hellkamp, Paul W Armstrong, et al.
American Heart Journal|November 19, 2011
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programCono A Ariti, John G F Cleland, Stuart J Pocock, et al.
European Heart Journal|September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndromePh Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.
The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.
Journal of Electrocardiology|January 1, 1994
From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoringM W Krucoff, C L Green, F E Harrell, et al.
Stroke|November 2, 2017
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or WarfarinDragos Vinereanu, Renato D Lopes, Hillary Mulder, et al.
American Heart Journal|March 5, 2019
Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM TrialAbhinav Sharma, Robert J Mentz, Bradi B Granger, et al.
Archives of Internal Medicine|February 25, 2009
Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsPeter R Sinnaeve, P Gabriel Steg, Keith A A Fox, et al.
American Heart Journal|March 12, 2011
High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaborationSanneke P M de Boer, Elizabeth H Barnes, Cynthia M Westerhout, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
Pageof 126